TaoMedAI/RareMedData huggingface dataset:
Gene: TET2
Phenotype: Easy fatigability (HP:0003388)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Amaurosis fugax (HP:0100576)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Bronchiectasis (HP:0002110)
Associated disease: IMMUNODEFICIENCY 75 (OMIM:619126)
Gene: TET2
Phenotype: Abnormal mast cell morphology (HP:0100494)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Abnormal mast cell morphology (HP:0100494)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Increased total neutrophil count (HP:0011897)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Abnormal platelet morphology (HP:0011875)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Paresthesia (HP:0003401)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Infantile onset (HP:0003593)
Associated disease: IMMUNODEFICIENCY 75 (OMIM:619126)
Gene: TET2
Phenotype: Hepatomegaly (HP:0002240)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Hepatomegaly (HP:0002240)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Hepatomegaly (HP:0002240)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Gastrointestinal hemorrhage (HP:0002239)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Recurrent respiratory infections (HP:0002205)
Associated disease: IMMUNODEFICIENCY 75 (OMIM:619126)
Gene: TET2
Phenotype: Megaloblastic erythroid hyperplasia (HP:0200143)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Insomnia (HP:0100785)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Chest pain (HP:0100749)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Myelofibrosis (HP:0011974)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Persistent EBV viremia (HP:0020072)
Associated disease: IMMUNODEFICIENCY 75 (OMIM:619126)
Gene: TET2
Phenotype: Refractory anemia with ringed sideroblasts (HP:0004828)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Acute myeloid leukemia (HP:0004808)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Acute myeloid leukemia (HP:0004808)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Hemangioma (HP:0001028)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Urticaria (HP:0001025)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Urticaria (HP:0001025)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Vertigo (HP:0002321)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Headache (HP:0002315)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Headache (HP:0002315)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Transient ischemic attack (HP:0002326)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Abnormal cerebral vascular morphology (HP:0100659)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Erythromelalgia (HP:0032147)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Abdominal cramps (HP:0032155)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Venous thrombosis (HP:0004936)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Venous thrombosis (HP:0004936)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Bone marrow hypocellularity (HP:0005528)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Bone marrow hypocellularity (HP:0005528)
Associated disease: Refractory anemia; Myelodysplastic neoplasm with low blasts; MDS-LB (ORPHA:98826)
Gene: TET2
Phenotype: Increased megakaryocyte count (HP:0005513)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Increased megakaryocyte count (HP:0005513)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Increased total basophil count (HP:0031807)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Chronic lymphatic leukemia (HP:0005550)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Myeloproliferative disorder (HP:0005547)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Abnormal bone marrow cell morphology (HP:0005561)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Abnormal bone marrow cell morphology (HP:0005561)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Decreased FasL-mediated apoptosis (HP:4000057)
Associated disease: IMMUNODEFICIENCY 75 (OMIM:619126)
Gene: TET2
Phenotype: Hypersplenism (HP:0001971)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Abnormal thrombosis (HP:0001977)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Extramedullary hematopoiesis (HP:0001978)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Macrocytic anemia (HP:0001972)
Associated disease: Refractory anemia; Myelodysplastic neoplasm with low blasts; MDS-LB (ORPHA:98826)
Gene: TET2
Phenotype: Increased total leukocyte count (HP:0001974)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Increased total leukocyte count (HP:0001974)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Increased total leukocyte count (HP:0001974)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Increased total leukocyte count (HP:0001974)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Increased total leukocyte count (HP:0001974)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Fever (HP:0001945)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Fever (HP:0001945)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Hypochromic anemia (HP:0001931)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Leukemia (HP:0001909)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Anemia (HP:0001903)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Anemia (HP:0001903)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Decreased total granulocyte count (HP:0001913)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Moderate global developmental delay (HP:0011343)
Associated disease: IMMUNODEFICIENCY 75 (OMIM:619126)
Gene: TET2
Phenotype: Cachexia (HP:0004326)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Peptic ulcer (HP:0004398)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Elevated total serum tryptase (HP:0031901)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Elevated total serum tryptase (HP:0031901)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Hematological neoplasm (HP:0004377)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Hematological neoplasm (HP:0004377)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Hematological neoplasm (HP:0004377)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Prolonged bleeding time (HP:0003010)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Hyposegmentation of neutrophil nuclei (HP:0011447)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Poikilocytosis (HP:0004447)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Arterial thrombosis (HP:0004420)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Arterial thrombosis (HP:0004420)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Elevated circulating alkaline phosphatase concentration (HP:0003155)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Abnormal cardiac ventricular function (HP:0030872)
Associated disease: Refractory anemia; Myelodysplastic neoplasm with low blasts; MDS-LB (ORPHA:98826)
Gene: TET2
Phenotype: Pallor (HP:0000980)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Pallor (HP:0000980)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Pallor (HP:0000980)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Purpura (HP:0000979)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Bruising susceptibility (HP:0000978)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Pruritus (HP:0000989)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Pruritus (HP:0000989)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Petechiae (HP:0000967)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Osteoporosis (HP:0000939)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Osteoporosis (HP:0000939)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Abnormal blistering of the skin (HP:0008066)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Maculopapular exanthema (HP:0040186)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Increased proportion of CD25+ mast cells (HP:0031408)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Autoimmune antibody positivity (HP:0030057)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Megakaryocyte nucleus hyperlobulation (HP:0031388)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Arthralgia (HP:0002829)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Arthralgia (HP:0002829)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Ascites (HP:0001541)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Myelodysplasia (HP:0002863)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Myelodysplasia (HP:0002863)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Myelodysplasia (HP:0002863)
Associated disease: MYELODYSPLASTIC SYNDROME (OMIM:614286)
Gene: TET2
Phenotype: Myelodysplasia (HP:0002863)
Associated disease: Refractory anemia; Myelodysplastic neoplasm with low blasts; MDS-LB (ORPHA:98826)
Gene: TET2
Phenotype: Myelodysplasia (HP:0002863)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Ecchymosis (HP:0031364)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Fatigue (HP:0012378)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Fatigue (HP:0012378)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Fatigue (HP:0012378)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Fatigue (HP:0012378)
Associated disease: Refractory anemia; Myelodysplastic neoplasm with low blasts; MDS-LB (ORPHA:98826)
Gene: TET2
Phenotype: Fatigue (HP:0012378)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Amyloidosis (HP:0011034)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Myeloid leukemia (HP:0012324)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Chronic myelomonocytic leukemia (HP:0012325)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Tachycardia (HP:0001649)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Myocardial infarction (HP:0001658)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Flank pain (HP:0030157)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Congestive heart failure (HP:0001635)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Low-grade fever (HP:0011134)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Abnormal skin morphology (HP:0011121)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Hepatic vein thrombosis (HP:0030243)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Splenomegaly (HP:0001744)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Splenomegaly (HP:0001744)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Splenomegaly (HP:0001744)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Splenomegaly (HP:0001744)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Multiple myeloma (HP:0006775)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Weight loss (HP:0001824)
Associated disease: Aggressive systemic mastocytosis (ORPHA:98850)
Gene: TET2
Phenotype: Weight loss (HP:0001824)
Associated disease: Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease; Systemic mastocytosis with associated hematologic neoplasm; SM-AHN; SM-AHNMD (ORPHA:98849)
Gene: TET2
Phenotype: Visual impairment (HP:0000505)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Abnormal bleeding (HP:0001892)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Abnormal bleeding (HP:0001892)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Abnormal bleeding (HP:0001892)
Associated disease: Refractory anemia; Myelodysplastic neoplasm with low blasts; MDS-LB (ORPHA:98826)
Gene: TET2
Phenotype: Abnormal bleeding (HP:0001892)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Thrombocytosis (HP:0001894)
Associated disease: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Osteomyelofibrosis; Primary myelofibrosis; Myelofibrosis with myeloid metaplasia (ORPHA:824)
Gene: TET2
Phenotype: Thrombocytosis (HP:0001894)
Associated disease: RARS; Acquired idiopathic sideroblastic anemia; AISA; Primary acquired sideroblastic anemia; Refractory anemia with ringed sideroblasts (ORPHA:75564)
Gene: TET2
Phenotype: Thrombocytosis (HP:0001894)
Associated disease: ET; Essential thrombocythemia; Essential thrombocytosis (ORPHA:3318)
Gene: TET2
Phenotype: Decreased class-switched memory B cell proportion (HP:0030388)
Associated disease: IMMUNODEFICIENCY 75 (OMIM:619126)